RecruitingPhase 2NCT06839989
An Immunogenicity and Safety Trial of MVA-BN in Adults Living With HIV for the Prevention of Mpox Infection, in Kinshasa, DRC
Studying Human infection by orthopoxvirus
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Institute of Tropical Medicine, Belgium
- Principal Investigator
- Laurens Liesenborghs, MDInstitute of Tropical Medicine
- Intervention
- Mpox vaccination with MVA-BN(biological)
- Enrollment
- 600 enrolled
- Eligibility
- 18-45 years · All sexes
- Timeline
- 2025 – 2025
Study locations (1)
- Centre Hospitalier Kabinda, Kinshasa, Democratic Republic of the Congo
Collaborators
MSF Médecins Sans Frontières Belgium · Institut National pour la Recherche Biomedicale (INRB)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06839989 on ClinicalTrials.govOther trials for Human infection by orthopoxvirus
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGPHASE2NCT07199569Comparability Trial of the MVA-BN Vaccine Manufactured in Different Production CellsBavarian Nordic
- ACTIVE NOT RECRUITINGPHASE3NCT06844487Phase 3 Infant Safety & Immunogenicity Trial of MVA-BN® in DRCJean-Pierre Van geertruyden
- RECRUITINGNCT06885853Evaluation of Long-term Immunogenicity of a Boost Dose of MVA-BN VaccineAssistance Publique - Hôpitaux de Paris
- RECRUITINGPHASE1NCT06771479A Study Evaluating the Safety and Immunogenicity of MVA Strain Monkeypox Attenuated Live VaccineShanghai Institute Of Biological Products
- ACTIVE NOT RECRUITINGPHASE2NCT06549530Open-label, Multicenter Immunogenicity and Safety Study of MVA-BN Vaccine in Children From 2 Years to Less Than 12 Years of Age Compared to Adults for the Prevention of Smallpox, Mpox, and Related Orthopoxvirus InfectionsBavarian Nordic
- ACTIVE NOT RECRUITINGEARLY PHASE1NCT06366672Evaluating the Human Immune Response to the JYNNEOS VaccineWashington University School of Medicine
- RECRUITINGNANCT05627713Clinical and Biological Aspects of the MONKEYPOX DiseaseInstitut Pasteur